Losartan competitively inhibits CYP2C8-dependent paclitaxel ...
2014-01-01
[Biol. Pharm. Bull. 37(9) , 1550-4, (2014)]
|
The potential of anti-vascular endothelial growth factor the...
2008-05-01
[Eur. J. Cancer 44(7) , 912-20, (2008)]
|
Advancing bioluminescence imaging technology for the evaluat...
2009-01-01
[Clin. Cancer Res. 15(1) , 238-46, (2009)]
|
Bevacizumab/docetaxel association is more efficient than doc...
2010-01-01
[Eur. J. Cancer 46 , 3022-36, (2010)]
|
Novel therapeutic strategies in development for prostate can...
2008-01-01
[Expert Opin. Investig. Drugs 17(1) , 13-22, (2008)]
|